CD4 and neoplasm: TGFβ produced by Bregs can increase the ability of TGFβR1 and TGFβR2 expressing MDSCs to produce cytotoxic reactive oxygen species and nitric oxide (NO), resulting in efficient inhibition of CD4+ and CD8+T cell anti-tumour responses [60].